These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 2704332)

  • 1. Similar chromosomal patterns and lack of N-myc gene amplification in localized and IV-S stage neuroblastomas in infants.
    Hayashi Y; Inaba T; Hanada R; Yamada M; Nakagome Y; Yamamoto K
    Med Pediatr Oncol; 1989; 17(2):111-5. PubMed ID: 2704332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytogenetic findings and prognosis in neuroblastoma with emphasis on marker chromosome 1.
    Hayashi Y; Kanda N; Inaba T; Hanada R; Nagahara N; Muchi H; Yamamoto K
    Cancer; 1989 Jan; 63(1):126-32. PubMed ID: 2910410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumour karyotype discriminates between good and bad prognostic outcome in neuroblastoma.
    Christiansen H; Lampert F
    Br J Cancer; 1988 Jan; 57(1):121-6. PubMed ID: 3348945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroblastoma. Effect of genetic factors on prognosis and treatment.
    Brodeur GM; Azar C; Brother M; Hiemstra J; Kaufman B; Marshall H; Moley J; Nakagawara A; Saylors R; Scavarda N
    Cancer; 1992 Sep; 70(6 Suppl):1685-94. PubMed ID: 1325279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Oncogene amplification in human neuroblastomas].
    Kanda N; Tsuchida Y; Hayashi Y; Ise T; Takayama J; Utakoji T
    Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 2):661-6. PubMed ID: 3963837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N-myc oncogene and stage IV-S neuroblastoma. Preliminary observations on ten cases.
    Nakagawara A; Sasazuki T; Akiyama H; Kawakami K; Kuwano A; Yokoyama T; Kume K
    Cancer; 1990 May; 65(9):1960-7. PubMed ID: 2196987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different karyotypic patterns in early and advanced stage neuroblastomas.
    Kaneko Y; Kanda N; Maseki N; Sakurai M; Tsuchida Y; Takeda T; Okabe I; Sakurai M
    Cancer Res; 1987 Jan; 47(1):311-8. PubMed ID: 3791218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic clinical markers of human neuroblastoma with special reference to N-myc oncogene: amplified or not amplified?--An overview.
    Tsuchida Y; Hemmi H; Inoue A; Obana K; Yang HW; Hayashi Y; Kanda N; Shimatake H
    Tumour Biol; 1996; 17(2):65-74. PubMed ID: 8658015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Tumor cytogenetics and prognosis in neuroblastoma].
    Christiansen H; Lampert F
    Monatsschr Kinderheilkd; 1989 Oct; 137(10):666-71. PubMed ID: 2586532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of N-myc amplification in relation to disease stage and histologic types in human neuroblastomas.
    Tsuda T; Obara M; Hirano H; Gotoh S; Kubomura S; Higashi K; Kuroiwa A; Nakagawara A; Nagahara N; Shimizu K
    Cancer; 1987 Aug; 60(4):820-6. PubMed ID: 3594401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of near-diploid DNA content and N-myc amplification in neuroblastomas.
    Dominici C; Negroni A; Romeo A; Castello MA; Clerico A; Scopinaro M; Mauro F; RaschellĂ  G
    Clin Exp Metastasis; 1989; 7(2):201-11. PubMed ID: 2920475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical significance of genetic rearrangements in human neuroblastomas.
    Brodeur GM
    Clin Chem; 1989 Jul; 35(7 Suppl):B38-42. PubMed ID: 2568197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Problems of mass screening for neuroblastoma: analysis of false-negative cases.
    Ishimoto K; Kiyokawa N; Fujita H; Yabuta K; Ohya T; Miyano T; Shinohara T; Sera Y
    J Pediatr Surg; 1990 Apr; 25(4):398-401. PubMed ID: 2329455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene amplification in human neuroblastomas: basic mechanisms and clinical implications.
    Brodeur GM; Seeger RC
    Cancer Genet Cytogenet; 1986 Jan; 19(1-2):101-11. PubMed ID: 3940169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical implications of oncogene activation in human neuroblastomas.
    Brodeur GM; Seeger RC; Sather H; Dalton A; Siegel SE; Wong KY; Hammond D
    Cancer; 1986 Jul; 58(2 Suppl):541-5. PubMed ID: 3719548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chromosome findings and prognosis in 15 patients with neuroblastoma found by VMA mass screening.
    Hayashi Y; Inaba T; Hanada R; Yamamoto K
    J Pediatr; 1988 Apr; 112(4):567-71. PubMed ID: 3351679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-myc amplification in multiple homogeneously staining regions in two human neuroblastomas.
    Emanuel BS; Balaban G; Boyd JP; Grossman A; Negishi M; Parmiter A; Glick MC
    Proc Natl Acad Sci U S A; 1985 Jun; 82(11):3736-40. PubMed ID: 2582423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N-myc oncogene expression and amplification in metastatic lesions of stage IV-S neuroblastoma.
    Garvin J; Bendit I; Nisen PD
    Cancer; 1990 Jun; 65(11):2572-5. PubMed ID: 1692506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined analysis of DNA ploidy index and N-myc genomic content in neuroblastoma.
    Bourhis J; De Vathaire F; Wilson GD; Hartmann O; Terrier-Lacombe MJ; Boccon-Gibod L; McNally NJ; Lemerle J; Riou G; BĂ©nard J
    Cancer Res; 1991 Jan; 51(1):33-6. PubMed ID: 1988094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evolution of tumor cytogenetic aberrations and N-myc oncogene amplification in a case of disseminated neuroblastoma.
    Christiansen H; Franke F; Bartram CR; Adolph S; Rudolph B; Harbott J; Reiter A; Lampert F
    Cancer Genet Cytogenet; 1987 Jun; 26(2):235-44. PubMed ID: 3567877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.